Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Sugammadex Injectable Product
Total 0 results
Nothing found
Sponsors and Collaborators
Eyal Ashkenazi
AtheroNova Inc.
LM Farma Indústria e Comércio Ltda.
Katarzyna Jórasz
Department of Emergency Medicine, The First People's Hospital of Hangzhou, Hangzhou, China.
MITO
Nottingham University Hospitals NHS Trust
E. Steve Woodle
Vituity Psychiatry
Asahi Kasei Medical Co., Ltd.
Yu-Hsiang Wu
BiondVax Pharmaceuticals ltd.
Bruno Rhiner
Camilla Wistrand
GenVivo, Inc.
STAG1 Gene Foundation
Virginia G. Kaklamani
Medical College Trivandrum
OLVG, Amsterdam, the Netherlands
Ministère de la Santé et l'Hygiène Publique, Mali
View Full List
Medical Conditions
Nondepolarising Muscle Relaxants
Intensive Care Neuropathy
Serum Bank
Phenoxymethylpenicillin
Cervical Cancer Stage IA2
Autism or Autistic Traits
Soft Tissue Sarcoma, Adult, Stage II
Stage IVA Lymphoepithelioma of the Oropharynx
Learning Disturbance
NR3C2
Patients Who Had the Urine Volume at Nighttime More Than One Third of Total Daily Urine Volume (NPU) and Voided More Than Two Times at Nighttime (Nocturia)
HPV-Related Anal Intraepithelial Neoplasia
Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))
Any Injury or Illness Acutely Impacting Work
Rotator Cuff Lesion
Synbiotics
Imaging, Diagnostic
Symptoms
Child Physical Activity
Mast-Cell Sarcoma
View Full List
Drug Interventions
Interleukin-2
Lidocaine/ ketamine
Transdermal estradiol
Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
CD25 treatment
Exendin 9-39
Extended release guanfacine
LDEPA
FHND5071
Rituximab plus CHOP
Thiotepa
Miglustat
Interferon beta-1b (Betaferon, BAY86-5046)
Methotrexate
5-Fluorouracil
Ozanimod
Insulin
Apremilast
Dexmedetomidine
View Full List
CROs by country
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Canada
Contract Research Organizations in Denmark
Contract Research Organizations in Egypt
Contract Research Organizations in Kosovo
Contract Research Organizations in Lebanon
Contract Research Organizations in Malaysia
Contract Research Organizations in Mauritania
Contract Research Organizations in Mexico
Contract Research Organizations in New Zealand
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Togo
Contract Research Organizations in Tunisia
CRO list by country
CROs in Kuwait
SGS
All CROs in Kuwait
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe